Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ARB and CCB longest combination treatment on ambulatory and home BP in hypertension with atrial fibrillation -Multicenter study on time of dosing

Trial Profile

ARB and CCB longest combination treatment on ambulatory and home BP in hypertension with atrial fibrillation -Multicenter study on time of dosing

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Amlodipine/telmisartan (Primary)
  • Indications Atrial fibrillation; Hypertension
  • Focus Therapeutic Use
  • Acronyms ACROBAT
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 29 Sep 2016 Results presented at the 26th Scientific Meeting of the International Society of Hypertension
    • 16 Mar 2016 Results published in the Journal of Clinical Hypertension (Greenwich)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top